Skip to main content
. 2018 Mar 21;27(3):438–455. doi: 10.1177/0963689718759473

Fig. 10.

Fig. 10.

Neuroprotective effects of cord blood serum–specific fraction with enhanced α-secretase catalytic activity (αCBSF). 5XFAD mice at 5 mo of age were treated intraperitoneally with αCBSF (n = 7) or aged blood serum fraction with enhanced α-secretase activity (AgBSF; n = 6) via osmotic mini pump for 6 wk. (A) Mouse brain sections from αCBSF- and AgBSF-treated groups were stained with anti-NeuN antibody. (B) Quantification of NeuN positive cells in the CA1, CA3, and neocortex revealed that αCBSF treatment significantly increased NeuN-positive cells compared with AgBSF treatment in neocortex (t-test for independent samples; *P < 0.05).